Funds Holding Neurocrine Biosciences, Inc.

 
Funds Holding Neurocrine Biosciences, Inc. top ^
  • Holdings: Cepheid, Hecla Mining Company, Hexcel Corporation, Genesee & Wyoming, Inc. Class A, Neurocrine Biosciences, Inc.
  • Category: Small Growth
  • Morningstar Rating: 1 Stars
Sign-up for ffscx investment picks
  • Holdings: Cepheid, Hecla Mining Company, Hexcel Corporation, Genesee & Wyoming, Inc. Class A, Neurocrine Biosciences, Inc.
  • Category: Small Growth
  • Morningstar Rating: 1 Stars
Sign-up for fscmx investment picks
  • Holdings: Cepheid, Hecla Mining Company, Hexcel Corporation, Genesee & Wyoming, Inc. Class A, Neurocrine Biosciences, Inc.
  • Category: Small Growth
  • Morningstar Rating: 2 Stars
Sign-up for ffhix investment picks

 
Stock Quotes for Neurocrine Biosciences, Inc. top ^
  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Speculative Growth
Sign-up for nbix investment picks
  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Speculative Growth
Sign-up for nbix investment picks

 
News Articles for Neurocrine Biosciences, Inc. top ^
2013/3/11
Live Audio Webcast Monday, March 18, 2013 SAN DIEGO , March 11, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Tim Coughlin , Chief Financial Officer of Neurocrine Biosciences, will be presenting at the 25 th Annual Roth Conference in Laguna Niguel.
Sign-up for Neurocrine Biosciences To Present At The 25th Annual Roth Conference investment picks
2013/2/6
Live Audio Webcast Wednesday, February 13, 2013 SAN DIEGO , Feb.
Sign-up for Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013 investment picks
2013/2/27
Live Audio Webcast Wednesday, March 6, 2013 SAN DIEGO , Feb.
Sign-up for Neurocrine Biosciences To Present At The Cowen And Company 33rd Annual Health Care Conference investment picks
2013/2/1
Conference Call and Webcast Scheduled For Friday, February 8, 2013 SAN DIEGO , Feb.
Sign-up for Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results investment picks
2013/3/27
STUDY WILL EVALUATE SIX MONTHS OF TREATMENT IN 280 SUBJECTS SAN DIEGO , March 27, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced that a Phase IIb clinical trial to evaluate elagolix for the treatment of uterine fibroids has been initiated.
Sign-up for Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids investment picks
2013/4/24
Live Audio Webcast Wednesday, May 1, 2013 SAN DIEGO , April 24, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman , President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Needham 12 th Annual Healthcare Conference in New York City.
Sign-up for Neurocrine Biosciences to Present at the Needham 12th Annual Healthcare Conference investment picks
2013/4/26
Conference Call and Webcast Scheduled For Thursday, May 2, 2013 SAN DIEGO , April 26, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its first quarter 2013 financial results after the Nasdaq market closes on Thursday,  May 2, 2013.
Sign-up for Neurocrine Biosciences Announces Conference Call And Webcast To Present First Quarter 2013 Financial Results investment picks
2013/5/2
ELAGOLIX ENTERS PHASE IIB FOR UTERINE FIBROIDS, ENDOMETRIOSIS PHASE III PROGRAM ON TRACK SAN DIEGO , May 2, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended March 31, 2013 .
Sign-up for Neurocrine Biosciences Reports First Quarter 2013 Results investment picks
2013/5/9
Live Audio Webcast Thursday, May 16, 2013 SAN DIEGO , May 9, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman , President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas.
Sign-up for Neurocrine Biosciences To Present At The Bank of America Merrill Lynch 2013 Health Care Conference investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Funds Holding Neurocrine Biosciences, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Funds Holding Neuberger Berman Focus INST  |  Next: Funds Holding Neustar, Inc.